Here are three things to know about Mr. Hosmer’s new position:
1. He will be responsible for Europe, Middle East and Africa as well as the international headquarters office in Amsterdam.
2. Mr. Hosmer was previously director of European sales for Bioventus and helped the company establish an international sales and operations presence. He has been with the company since its inception in 2012.
3. Before joining Bioventus, Mr. Hosmer has experience working for Smith & Nephew in leadership positions. He was director of Canadian commercialization for the company’s biologics and spine business.
Here are three things to know about Ms. Levy-Unger:
1. She joined Bioventus in April 2013 and previously served as the director of international commercial operations for the Americas and director of operational excellence. In her new position, Ms. Levy-Unger will be responsible for Canada, Latin America and Asia.
2. Ms. Levy-Unger has previous experience with Grifols, formerly known as Talecris Biotherapeutics, where she was director of European commercial operations and senior director of international operations as well as head of sales.
3. Ms. Levy-Unger is fluent in three languages and holds a postgraduate degree in negotiation and international business.
More articles on orthopedic devices:
10 trends to note in the knee implant market
8 trends in the North American neurosurgery market
5 predictions about the 2012-2018 bio-implant market
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
